Short Interest in NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Expands By 1,188.9%

NLS Pharmaceutics Ltd. (NASDAQ:NLSPWGet Free Report) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 11,600 shares, an increase of 1,188.9% from the December 31st total of 900 shares. Based on an average trading volume of 37,600 shares, the days-to-cover ratio is currently 0.3 days.

NLS Pharmaceutics Stock Up 2.6 %

Shares of NLS Pharmaceutics stock traded up $0.00 during trading on Tuesday, hitting $0.01. 69,282 shares of the stock were exchanged, compared to its average volume of 55,611. NLS Pharmaceutics has a 1-year low of $0.01 and a 1-year high of $0.10. The company has a fifty day moving average price of $0.01 and a 200-day moving average price of $0.02.

About NLS Pharmaceutics

(Get Free Report)

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).

Further Reading

Receive News & Ratings for NLS Pharmaceutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NLS Pharmaceutics and related companies with MarketBeat.com's FREE daily email newsletter.